A study of liver disease without cirrhosis
Part of Digestive system clinical trials.
This study looks at people with a rare liver condition called porto-sinusoidal vascular disorder (PSVD), where blood flow in the liver is abnormal but no cirrhosis is present. Researchers want to learn what causes it and how it affects patients over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a liver biopsy that confirmed PSVD
- The biopsy sample was at least about the size of a fingertip and showed no cirrhosis
- You meet the formal criteria for PSVD
- You have no other major liver diseases or liver cancer
- You are 18 years or older
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests non-invasive methods to diagnose a liver condition called PSVD in people who have received platinum chemotherapy. It may help find liver problems early without a biopsy.
This study tracks people with liver cirrhosis to see how often portal vein thrombosis (a blood clot in the main vein to the liver) occurs and how it can be treated with blood thinners. It aims to improve care for those at risk of these clots.
This study uses a special ultrasound with a contrast agent to see if it can diagnose PSVD (a rare liver vessel disorder) without a biopsy. It compares people with PSVD to those with cirrhosis to find better, noninvasive ways to detect this condition.
This trial looks at people with clinically significant portal hypertension, which is high blood pressure in the liver's blood vessels. It may help find better ways to manage this condition.
This trial is for people with liver cirrhosis who have high blood pressure in the vein that carries blood to the liver (portal hypertension). It uses a special ultrasound with contrast to learn more about the condition.
This study observes people who have both abnormal blood vessels connecting the liver and lungs (portosystemic shunts) and high blood pressure in the lungs (pulmonary hypertension). The goal is to learn more about how these conditions interact and how they progress over time.
Hear when a new Porto-Sinusoidal Vascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.